SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

PLoS One. 2018;13(9):e0201308.

Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.

, , , , , ,

제1저자 최윤진 · 교신저자 이동호

소속 (4)
  1. Department of Internal Medicine and Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, South Korea.
  2. Department of Internal Medicine, Korea University Guro Hospital, Guro-gu, Seoul, South Korea.
  3. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  4. Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Abstract

BACKGROUND Growing evidence supports that prostate cancer (PCa) is a metabolic syndrome-related cancer, but the evidence is lacking regarding the association between nonalcoholic fatty liver disease (NAFLD) and PCa. We aimed to investigate whether PCa is related with NAFLD in Korean adults.

METHODS Data from the National Health Insurance Corporation between 2009 and 2012 were analyzed using multivariate logistic regression method. NALFD was defined based on the fatty liver index (FLI) and hepatic steatosis index (HSI). Newly diagnosed PCa was identified using the claims data.

RESULTS NAFLD based on FLI and HSI was identified in 2,002,375 (19%) and 2,629,858 (25%) of 10,516,985 subjects, respectively. Each FLI ≥ 60 and HSI ≥ 36 was independently associated with the development of PCa after adjusting for other confounders (hazard ratio (HR) 1.09, 95% CI: 1.06-1.12 and HR 1.19, 95% CI: 1.16-1.23). The association was more prominent among those who were older (FLI, ≥ 65 years old and HSI, ≥ 40 years old), were not currently smoking, were presently consuming alcohol (< 30g/day) and had null components of metabolic syndrome than each counterpart. Non-obese persons with NAFLD defined by HSI had a higher risk of developing PCa than those with body mass index > 25 Kg/m2.

CONCLUSIONS NAFLD defined by FLI or HSI may help identify high-risk individuals for developing PCa particular in the elderly, even in the absence of obesity or metabolic syndrome. Future studies on this topic should necessarily be repeated based on ultrasonographic findings.

Figures

Fig 1
Fig 1 Flowchart showing the enrolment process for the study cohort. NHIC, National Health Insurance Corporation.
Fig 2
Fig 2 The impact of on the risk nonalcoholic fatty liver disease of prostate cancer in different subgroups. Forrest plots of hazard ratios (HR) and 95% confidential interval (CI) adjusted for age, smoking, drinking, regular exercise, income according to subgroups were illustrated. Fatty liver index (a) or hepatic steatosis index (b) was used to define the nonalcoholic fatty liver disease.

그림 출처: PubMed Central 공개 논문 (PMC6145525)

Conflict of interest statement

The authors have declared that no competing interests exist.

그 밖의 정보
출판 형태
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
저널
PloS one · eISSN 1932-6203
전자 출판
2018-09-19
MeSH
Adult · Age Factors · Alcohol Drinking / adverse effects / epidemiology · Humans · Male · Metabolic Syndrome / complications / epidemiology · Middle Aged · Non-alcoholic Fatty Liver Disease / classification / epidemiology · Prostatic Neoplasms / epidemiology · Republic of Korea / epidemiology · Risk Factors · Smoking / adverse effects / epidemiology
참고문헌
45편